Kemal Duru N, Morshedi M, Oehninger S
The BBB is a major obstacle for many drugs, especially large molecules like peptides, in reaching the central nervous system
Retatrutide dosage for special populations Retatrutide dosage may vary for the elderly, patients with chronic kidney disease, liver and kidney failure, diabetes, cardiovascular disease, and other health conditions
BPC-157 offers a different approach by directly supporting the healing mechanisms that tendons need
The safety and effectiveness of BPC-157 have not been thoroughly evaluated in humans
Therefore, it's unclear if the improvements were due to BPC 157 or simply the passage of time